FDA Sets Action Date of April 23, 2010 for Review of Pixantrone NDA – Based on the user fee goal date – April 23, if pixantrone is approved, CTI estimates that pixantrone could be available to patients in the U.S. early in the second quarter of 2010.
1 comment:
FDA Sets Action Date of April 23, 2010 for Review of Pixantrone NDA – Based on the user fee goal date – April 23, if pixantrone is approved, CTI estimates that pixantrone could be available to patients in the U.S. early in the second quarter of 2010.
Post a Comment